BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
ERIS Lifesciences Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
540596
ISIN Demat
INE406M01024
Book Value (Rs)
230.5357014
NSE Symbol
ERIS
Divident Yield %
0.54
Market Cap
(Rs In Cr.)
18,593
P/E (TTM)
62.6
EPS (TTM)
21.44
Face Value
(Rs)
1
Back
ERIS Lifesciences consolidated net profit rises 31.23% in the September 2025 quarter
14-Nov-25   Hrs IST

Net profit of ERIS Lifesciences rose 31.23% to Rs 120.19 crore in the quarter ended September 2025 as against Rs 91.59 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 790.15 crore in the quarter ended September 2025 as against Rs 738.95 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales790.15738.95 7
OPM %36.4835.80 -
PBDT241.75209.59 15
PBT172.67129.11 34
NP120.1991.59 31

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)